US81663L2007 - Common Stock
GENEDX HOLDINGS CORP
NASDAQ:WGS (4/26/2024, 2:46:07 PM)
11.05
-0.12 (-1.07%)
GeneDx Holdings Corp. is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,100 full-time employees. The company went IPO on 2020-09-04. The firm is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company’s segments are GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women’s health and somatic oncology diagnostic testing and screening products.
GENEDX HOLDINGS CORP
333 Ludlow Street, North Tower, 8Th Floor
Stamford CONNECTICUT
P: 16177808742
Employees: 1100
Website: https://sema4.com/
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision...
Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time. ...
Here you can normally see the latest stock twits on WGS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: